Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome (Q34207805)

31 July 2017

1 reference

title

Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome (English)

1 reference

31 July 2017

1 reference

hepatocellular carcinoma

1 reference

Gar-Yang Chau

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2014

1 reference

World Journal of Gastroenterology

31 July 2017

published in

1 reference

31 July 2017

volume

20

1 reference

31 July 2017

issue

35

1 reference

31 July 2017

page(s)

12473-12484

1 reference

Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Recipient outcomes of salvage liver transplantation versus primary liver transplantation: A systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Hepatocellular carcinoma: the point of view of the hepatitis B virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Risk factors for residual tumor after resection of hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Targeted therapies for hepatocellular carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Pretreatment assessment of hepatocellular carcinoma: expert consensus statement

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

CT and MRI of hepatocellular carcinoma: an update

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Hepatitis B: liver fibrosis and hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Sorafenib in advanced hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Natural history of hepatitis-related hepatocellular carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Management of hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Primary liver cancer: worldwide incidence and trends

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Lamivudine for patients with chronic hepatitis B and advanced liver disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

5 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Ultrasonically guided subsegmentectomy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Hepatic function and liver resection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score

5 July 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Current management strategy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Hepatic resection can provide long-term survival of patients with non–early-stage hepatocellular carcinoma: Extending the Indication for resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Large hepatocellular carcinoma: time to stop preoperative biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Prognostic impact of marginal resection for patients with solitary hepatocellular carcinoma: Evidence from 570 hepatectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4168080

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

28 October 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V20.I35.12473

Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience

21 January 2018

1 reference

12 December 2020

Risk factors associated with intra-operative major blood loss in patients with hepatocellular carcinoma who underwent hepatic resection

1 reference

12 December 2020

Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome

1 reference

12 December 2020

Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma

1 reference

12 December 2020

Extrahepatic division of the right hepatic vein in hepatectomy

1 reference

12 December 2020

Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma

1 reference

12 December 2020

The prognostic significance of surgical margin in liver resection of patients with hepatocellular carcinoma

1 reference

12 December 2020

Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma

1 reference

12 December 2020

Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal

1 reference

12 December 2020

Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma

1 reference

12 December 2020

Anterior approach for difficult major right hepatectomy.

1 reference

12 December 2020

Prognostic significance of surgical margin in hepatocellular carcinoma resection: An analysis of 165 Childs' A patients

1 reference

12 December 2020

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial

1 reference

12 December 2020

Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy

1 reference

12 December 2020

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths

1 reference

12 December 2020

Prognostic impact of anatomic resection for hepatocellular carcinoma

1 reference

12 December 2020

Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study

1 reference

12 December 2020

Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial

1 reference

12 December 2020

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes

1 reference

12 December 2020

Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection

1 reference

12 December 2020

Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival

1 reference

12 December 2020

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

1 reference

12 December 2020

Second and third hepatectomies for recurrent hepatocellular carcinoma are justified

1 reference

12 December 2020

Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma

1 reference

12 December 2020

Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis

1 reference

12 December 2020

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma

1 reference

12 December 2020

Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma

1 reference

12 December 2020

10.3748/WJG.V20.I35.12473

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference